What Nippon India Pharma Fund bought and sold in September 2026
This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of Nippon India Mutual Fund.
Nippon India Pharma Fund Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
| Sai Life Sciences Limited | Reduced | −7.8% | 3.92% |
|---|---|---|---|
| Abbott India Limited | Added | +0.5% | 2.32% |
| Indoco Remedies Limited | Reduced | −8.4% | 0.48% |
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Frequently Asked Questions
Which new stocks did Nippon India Pharma Fund buy in September 2026?
Nippon India Pharma Fund bought no new stocks in September 2026.
Which stocks did Nippon India Pharma Fund sell completely in September 2026?
Nippon India Pharma Fund did not sell any stock completely in September 2026.
Which stocks did Nippon India Pharma Fund buy more of in September 2026?
The largest increases in shares held were Abbott India Limited (+0.5%).
Which stocks did Nippon India Pharma Fund sell part of in September 2026?
The largest cuts in shares held were Indoco Remedies Limited (−8.4%) and Sai Life Sciences Limited (−7.8%).
How are these changes worked out?
WealthGamma compares the number of shares Nippon India Pharma Fund held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of Nippon India Mutual Fund. A change in share price alone does not count as buying or selling.
See NAV, expense ratio and full holdings of Nippon India Pharma Fund
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.